Job Description
Houston based Biotech company developing cancer drug candidates is seeking a Medical Director consultant to work with the CEO to evaluate clinical program outcomes. Company has several clinical trials ongoing including a Phase 2. Qualifications include an M.D. with clinical development experience with AML drug candidates. Company Description
Bio-Path is a biotechnology company developing targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company’s lead product candidate, prexigebersen (Liposomal Grb2 Antisense), formerly BP1001, is currently being assessed in a Phase 2 clinical study in 54 people with previously untreated AML who are not eligible for or who have decided to forego intensive induction therapy because of their age or fragile health.